289 related articles for article (PubMed ID: 25336150)
1. Molecular-target-based anticancer photosensitizer: synthesis and in vitro photodynamic activity of erlotinib-zinc(II) phthalocyanine conjugates.
Zhang FL; Huang Q; Liu JY; Huang MD; Xue JP
ChemMedChem; 2015 Feb; 10(2):312-20. PubMed ID: 25336150
[TBL] [Abstract][Full Text] [Related]
2. Synthesis and in vitro anticancer activity of zinc(II) phthalocyanines conjugated with coumarin derivatives for dual photodynamic and chemotherapy.
Zhou XQ; Meng LB; Huang Q; Li J; Zheng K; Zhang FL; Liu JY; Xue JP
ChemMedChem; 2015 Feb; 10(2):304-11. PubMed ID: 25369981
[TBL] [Abstract][Full Text] [Related]
3. A novel strategy for targeting photodynamic therapy. Molecular combo of photodynamic agent zinc(II) phthalocyanine and small molecule target-based anticancer drug erlotinib.
Zhang FL; Huang Q; Zheng K; Li J; Liu JY; Xue JP
Chem Commun (Camb); 2013 Oct; 49(83):9570-2. PubMed ID: 24018863
[TBL] [Abstract][Full Text] [Related]
4. Silicon Phthalocyanines Axially Disubstituted with Erlotinib toward Small-Molecular-Target-Based Photodynamic Therapy.
Chen JJ; Huang YZ; Song MR; Zhang ZH; Xue JP
ChemMedChem; 2017 Sep; 12(18):1504-1511. PubMed ID: 28776965
[TBL] [Abstract][Full Text] [Related]
5. Far-red-absorbing cationic phthalocyanine photosensitizers: synthesis and evaluation of the photodynamic anticancer activity and the mode of cell death induction.
Machacek M; Cidlina A; Novakova V; Svec J; Rudolf E; Miletin M; Kučera R; Simunek T; Zimcik P
J Med Chem; 2015 Feb; 58(4):1736-49. PubMed ID: 25599409
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and in vitro photodynamic activity of oligomeric ethylene glycol-quinoline substituted zinc(II) phthalocyanine derivatives.
Jia X; Yang FF; Li J; Liu JY; Xue JP
J Med Chem; 2013 Jul; 56(14):5797-805. PubMed ID: 23786380
[TBL] [Abstract][Full Text] [Related]
7. Enhanced photodynamic efficacy of zinc phthalocyanine by conjugating to heptalysine.
Li L; Luo Z; Chen Z; Chen J; Zhou S; Xu P; Hu P; Wang J; Chen N; Huang J; Huang M
Bioconjug Chem; 2012 Nov; 23(11):2168-72. PubMed ID: 23057652
[TBL] [Abstract][Full Text] [Related]
8. The first silicon(IV) phthalocyanine-nucleoside conjugates with high photodynamic activity.
Shen XM; Zheng BY; Huang XR; Wang L; Huang JD
Dalton Trans; 2013 Aug; 42(29):10398-403. PubMed ID: 23774802
[TBL] [Abstract][Full Text] [Related]
9. Asymmetric ZnPc-rhodamine B conjugates for mitochondrial targeted photodynamic therapy.
Muli DK; Rajaputra P; You Y; McGrath DV
Bioorg Med Chem Lett; 2014 Sep; 24(18):4496-4500. PubMed ID: 25150377
[TBL] [Abstract][Full Text] [Related]
10. A zinc(II) phthalocyanine conjugated with an oxaliplatin derivative for dual chemo- and photodynamic therapy.
Lau JT; Lo PC; Fong WP; Ng DK
J Med Chem; 2012 Jun; 55(11):5446-54. PubMed ID: 22646131
[TBL] [Abstract][Full Text] [Related]
11. Intracellular photodynamic therapy with photosensitizer-nanoparticle conjugates: cancer therapy using a 'Trojan horse'.
Wieder ME; Hone DC; Cook MJ; Handsley MM; Gavrilovic J; Russell DA
Photochem Photobiol Sci; 2006 Aug; 5(8):727-34. PubMed ID: 16886087
[TBL] [Abstract][Full Text] [Related]
12. Carboxymethyl chitosan-zinc(II) phthalocyanine conjugates: Synthesis, characterization and photodynamic antifungal therapy.
Tang F; Gao F; Xie W; Li S; Zheng B; Ke M; Huang J
Carbohydr Polym; 2020 May; 235():115949. PubMed ID: 32122485
[TBL] [Abstract][Full Text] [Related]
13. Fully protected glycosylated zinc (II) phthalocyanine shows high uptake and photodynamic cytotoxicity in MCF-7 cancer cells.
Kimani SG; Shmigol TA; Hammond S; Phillips JB; Bruce JI; MacRobert AJ; Malakhov MV; Golding JP
Photochem Photobiol; 2013; 89(1):139-49. PubMed ID: 22803957
[TBL] [Abstract][Full Text] [Related]
14. Lenvatinib-zinc phthalocyanine conjugates as potential agents for enhancing synergistic therapy of multidrug-resistant cancer by glutathione depletion.
Wei G; Huang L; Jiang Y; Shen Y; Huang Z; Huang Y; Sun X; Zhao C
Eur J Med Chem; 2019 May; 169():53-64. PubMed ID: 30856406
[TBL] [Abstract][Full Text] [Related]
15. A non-aggregated zinc(II) phthalocyanine with hexadeca cations for antitumor and antibacterial photodynamic therapies.
Zheng BD; Li SL; Huang ZL; Zhang L; Liu H; Zheng BY; Ke MR; Huang JD
J Photochem Photobiol B; 2020 Dec; 213():112086. PubMed ID: 33232881
[TBL] [Abstract][Full Text] [Related]
16. Phthalocyanine derivatives possessing 2-(morpholin-4-yl)ethoxy groups as potential agents for photodynamic therapy.
Kucinska M; Skupin-Mrugalska P; Szczolko W; Sobotta L; Sciepura M; Tykarska E; Wierzchowski M; Teubert A; Fedoruk-Wyszomirska A; Wyszko E; Gdaniec M; Kaczmarek M; Goslinski T; Mielcarek J; Murias M
J Med Chem; 2015 Mar; 58(5):2240-55. PubMed ID: 25700089
[TBL] [Abstract][Full Text] [Related]
17. Synthesis and in vitro photodynamic activities of di-alpha-substituted zinc(ii) phthalocyanine derivatives.
Liu JY; Lo PC; Jiang XJ; Fong WP; Ng DK
Dalton Trans; 2009 Jun; (21):4129-35. PubMed ID: 19452061
[TBL] [Abstract][Full Text] [Related]
18. Synthesis of phthalocyanine conjugates with gold nanoparticles and liposomes for photodynamic therapy.
Nombona N; Maduray K; Antunes E; Karsten A; Nyokong T
J Photochem Photobiol B; 2012 Feb; 107():35-44. PubMed ID: 22209036
[TBL] [Abstract][Full Text] [Related]
19. A non-aggregated and tumour-associated macrophage-targeted photosensitiser for photodynamic therapy: a novel zinc(II) phthalocyanine containing octa-sulphonates.
Li XS; Ke MR; Zhang MF; Tang QQ; Zheng BY; Huang JD
Chem Commun (Camb); 2015 Mar; 51(22):4704-7. PubMed ID: 25692672
[TBL] [Abstract][Full Text] [Related]
20. Improved photodynamic efficacy of thiophenyl sulfonated zinc phthalocyanine loaded in lipid nano-carriers for hepatocellular carcinoma cancer cells.
Abdel Fadeel D; Al-Toukhy GM; Elsharif AM; Al-Jameel SS; Mohamed HH; Youssef TE
Photodiagnosis Photodyn Ther; 2018 Sep; 23():25-31. PubMed ID: 29870793
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
